Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors - Wikidata - wikimedia - TriplyDB

Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors

Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors

http://www.wikidata.org/entity/Q36512525

about

Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy Construction of Various γ34.5 Deleted Fluorescent-Expressing Oncolytic herpes Simplex type 1 (oHSV) for Generation and Isolation of HSV-Based Vectors Enhancing the bystander killing effect of an oncolytic HSV by arming it with a secretable apoptosis activator.Designing Herpes Viruses as Oncolytics.EXPLORING THE ANTITUMOR EFFECT OF VIRUS IN MALIGNANT GLIOMA Transient fasting enhances replication of oncolytic herpes simplex virus in glioblastoma.TRAIL on trial: preclinical advances in cancer therapy The potential application of a transcriptionally regulated oncolytic herpes simplex virus for human cancer therapy.Glioma virus therapies between bench and bedside.Evolution of oncolytic viruses: novel strategies for cancer treatment.Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models.Immune and viral therapies for malignant primary brain tumors.Stem cell-released oncolytic herpes simplex virus has therapeutic efficacy in brain metastatic melanomas.Therapeutic targeting of chemoresistant and recurrent glioblastoma stem cells with a proapoptotic variant of oncolytic herpes simplex virus.microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis.VP2 capsid domain of the H-1 parvovirus determines susceptibility of human cancer cells to H-1 viral infection.Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy.MRSI-based molecular imaging of therapy response to temozolomide in preclinical glioblastoma using source analysis.

P2860

Q26998111-16F72117-6683-4DBF-AA99-EF9D6B049EC8 Q33766379-6ACBCF52-77F6-4187-B7E0-5420D5C9CBF2 Q35154965-40970F35-C126-4976-836E-7DC9D01E1D1A Q36142487-9A9E037D-848C-4616-BD34-6756D6136E16 Q36549443-C08582C4-685E-4D09-A609-5535F0117ED4 Q36878711-F28462F4-0B50-4165-9256-BE51144E9003 Q37433463-7DF6DCC4-39DC-4106-BC04-B17447C9212A Q37459624-EEF5B072-80B0-4C54-8241-A616D2B9E32E Q37580510-D0208011-0548-4053-9510-69B8FE32489D Q38159802-87066B3B-7B2B-46EB-8B49-C8F37079B2AB Q38400073-8D39FBC0-0F19-4E6A-AF8F-48EDB1FEFA91 Q39168899-9BFFA313-201F-40BF-AD60-0E26F30C3686 Q40122051-A6D91690-9711-408F-AEEE-B4E52303C9DC Q40178043-D2501E16-2BB3-4B7E-B68E-F95ACA61B1E8 Q41920847-DE7F1945-6D33-4D02-ADA8-B57C915BB006 Q42149771-161838EA-DDF0-4966-A643-D988A90318B1 Q42218017-54BAE257-305E-46A4-8990-0EB1B07BA0E4 Q50671051-97234969-4674-425D-BBB7-D20E6F4CEBB2

P2860

Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors

http://www.wikidata.org/entity/Q36512525

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors

@ast

Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors

@en

type

label

Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors

@ast

Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors

@en

prefLabel

Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors

@ast

Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors

@en

P1433

Q36512525-E978562C-DAB8-4FDF-B16D-75838FD12923

P1476

Q36512525-30A0630A-172A-49FC-A1F0-48A3A06DDEF8

P2093

Q36512525-508F2741-72A1-4EC2-81B2-F81E6C065BAD

Q36512525-725BA35D-B378-4B4A-B85E-627DC54150D3

Q36512525-8186EF1D-DE3C-450C-95E3-4BA0F0BA9DE8

Q36512525-8C97C995-7CC9-453D-A7CB-E65FF16C41F4

Q36512525-C98C5630-6109-4CA9-A150-A541F1B8E085

Q36512525-E5DD0FA4-3D64-4920-A73A-0F5757C38BF2

P2860

Q36512525-00628C2A-ADA2-47B3-8C73-438A3CECFA52

Q36512525-035CA626-D6E6-4246-A114-C8D70F4FFDAB

Q36512525-057E3C2D-CB1C-4142-AF8C-FA1526122BA4

Q36512525-062A5ED8-B8F0-44D1-91B3-71351E8979B6

Q36512525-0FC7587A-2677-4525-8C74-FA14BA5BB511

Q36512525-11CC33C1-F4E6-46D8-8A2E-5CBB0B523009

Q36512525-178C3063-E8A1-43DD-AA08-7EAC47516271

Q36512525-2E1C5C6B-DE1F-4633-8D77-11AE6A08BB4D

Q36512525-49EE1F4A-AD07-479D-90FA-C8359912B82B

Q36512525-4ABD16EB-AC17-46C5-A318-162561193E29

P304

Q36512525-B533EE75-D567-4F51-886C-CD402491B9EE

P31

Q36512525-E7C82FED-FD8D-40BA-A960-7E9D2BB9155F

P356

Q36512525-06D13930-0999-4FC3-B75F-6958F056DF1A

P433

Q36512525-8AF13629-D30A-4DFA-80CE-2F89274ADD02

P478

Q36512525-8C64AD2C-83C1-4C42-A74E-86EF97910224

P50

Q36512525-6144BA59-28AF-45E8-BE7C-43B1F08FF52F

Q36512525-7D00E63D-08FC-4C70-B44A-EB8090B8A41A

Q36512525-AF9744BC-0BEE-4711-B6EB-E3F660626E25

P577

Q36512525-53E12E20-8D5B-40EA-926C-C45477667B16

P5875

Q36512525-6499E899-6ADC-4B49-BEE2-354CA55976E4

P698

Q36512525-521D7E37-F8D6-497D-9755-5C85FD708ED8

P921

Q36512525-D0BC5E8E-1262-41CD-BF30-9DF5CE6A612F

P932

Q36512525-29B34A97-4561-49B9-875F-B94935AAFEEF

P356

P1433

Molecular Therapy

P1476

Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors

@en

P2093

Aayush S Agarwal

http://www.w3.org/2001/XMLSchema#string

Deepak Bhere

http://www.w3.org/2001/XMLSchema#string

Hiroaki Wakimoto

http://www.w3.org/2001/XMLSchema#string

Kaoru Tamura

http://www.w3.org/2001/XMLSchema#string

Khalid Shah

http://www.w3.org/2001/XMLSchema#string

Randa Kasmieh

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Oncolytic herpes simplex virus vectors for cancer virotherapy

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis

Malignant gliomas in adults

Programmed cell death in animal development

Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases.

Engineering a leucine zipper-TRAIL homotrimer with improved cytotoxicity in tumor cells

Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial.

P304

68-77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2012.175

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Toshihiko Kuroda

Samuel D Rabkin

Robert L Martuza

P577

2012-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230755740

http://www.w3.org/2001/XMLSchema#string

P698

22929661

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

3538303

http://www.w3.org/2001/XMLSchema#string